Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Feng Mao"'
Autor:
Changjun Wang, Yidong Zhou, Yan Lin, Feng Mao, Jinghong Guan, Xiaohui Zhang, Songjie Shen, Xuejing Wang, Yanna Zhang, Bo Pan, Ying Zhong, Li Peng, Xi Cao, Ru Yao, Xingtong Zhou, Chi Xu, Ying Xu, Qiang Sun
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background The de-escalation treatment in patients with low-risk HER2-positive early breast cancer (eBC) is an attractive strategy to avoid unnecessary treatment and improve the quality of life of patients. Pyrotinib, a novel irreversible pa
Externí odkaz:
https://doaj.org/article/5de610aa3b904bbbb4e984ebf7100a4d
Autor:
Changjun Wang, Yan Lin, Yidong Zhou, Feng Mao, Hanjiang Zhu, Jinghong Guan, Xiaohui Zhang, Songjie Shen, Xin Huang, Chang Chen, Ru Yao, Jialin Zhao, Qiang Sun
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)
Abstract Background HER2 dual-blockade combined with aromatase inhibitors (AI) is a promising strategy to improve progression-free survival (PFS) in hormone receptor (HR) positive, metastatic breast cancer (MBC). Pyrotinib is a novel irreversible epi
Externí odkaz:
https://doaj.org/article/b6b4f72db84445c98b33c06af40d65ff
Autor:
Yidong Zhou, Yan Li, Feng Mao, Jing Zhang, Qingli Zhu, Songjie Shen, Yan Lin, Xiaohui Zhang, He Liu, Mengsu Xiao, Yuxin Jiang, Qiang Sun
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background This preliminary study aimed to examine the feasibility of sentinel lymph node biopsy (SLNB) using contrast-enhanced ultrasound (CEUS) vs. indocyanine green fluorescence (ICG), combined with blue dye in patients with breast cancer
Externí odkaz:
https://doaj.org/article/7844c4d7e8ba44128d162c1f345da867
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Thirty to 40 % of non-small cell lung cancer (NSCLC) patients developed higher hypertriglyceridemia in the process of treatment with bexarotene. And bioinformatics studies discovered that the expression of slc10a2 was increased in
Externí odkaz:
https://doaj.org/article/0a334ee32f4c470f99ca55287c4b7484
Autor:
Feng Mao, Jinghong Guan, Yan Lin, Chang Chen, Xiaohui Zhang, Songjie Shen, Yidong Zhou, Xin Huang, Jialin Zhao, Ru Yao, Changjun Wang, Qiang Sun, Hanjiang Zhu
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-6 (2020)
BMC Cancer
BMC Cancer
Background HER2 dual-blockade combined with aromatase inhibitors (AI) is a promising strategy to improve progression-free survival (PFS) in hormone receptor (HR) positive, metastatic breast cancer (MBC). Pyrotinib is a novel irreversible epidermal gr
Autor:
Yan Lin, Qiang Sun, He Liu, Jing Zhang, Feng Mao, Songjie Shen, Yidong Zhou, Yuxin Jiang, Xiaohui Zhang, Qingli Zhu, Mengsu Xiao, Yan Li
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Cancer
BMC Cancer
Background This preliminary study aimed to examine the feasibility of sentinel lymph node biopsy (SLNB) using contrast-enhanced ultrasound (CEUS) vs. indocyanine green fluorescence (ICG), combined with blue dye in patients with breast cancer. Methods
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer
BMC Cancer
Background Thirty to 40 % of non-small cell lung cancer (NSCLC) patients developed higher hypertriglyceridemia in the process of treatment with bexarotene. And bioinformatics studies discovered that the expression of slc10a2 was increased in high-gra
Publikováno v:
BMC Cancer; 2014, Vol. 14 Issue 1, p1-19, 19p